'Numbness of the feet' is a poor indicator for polyneuropathy in Type 2 diabetic patients

Diabetic Medicine

Volumn 17, Issue 2, 2000, Pages 105-110

  Franse, Lonneke V ^a   Valk, G D ^a   Dekker, J H ^a   Heine, R J ^a,b   Van Eijk, J T M ^c  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c NONE

Author keywords

Diabetic neuropathies; Neurological examination; Primary healthcare; Type 2 diabetes mellitus

Indexed keywords

AGED; ARTICLE; DIABETIC NEUROPATHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FEMALE; FOOT; GENERAL PRACTICE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PARESTHESIA;

AGED; AGING; DIABETES MELLITUS, TYPE 2; DIABETIC FOOT; DIABETIC NEUROPATHIES; FOOT DISEASES; HUMANS; HYPESTHESIA; SENSITIVITY AND SPECIFICITY;

EID: 0034064549     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.2000.00223.x     Document Type: Article

References (27)

1. 1 de Sonnaville JJ, Colly LP, Wijkel D, Heine RJ. The prevalence and determinants of foot ulceration in type II diabetic patients in a primary health care setting. Diabetes Res Clin Pract 1997; 35: 149-156.
2. 2 Wagner FWJ. The dysvascular foot: a system for diagnosis and treatment. Foot Ankle 1981; 2: 64-122.
3. 3 Lavery LA, van Houtum WH, Harkless LB. In-hospital mortality and disposition of diabetic amputees in The Netherlands. Diabet Med 1996; 13: 192-197.
4. 4 Bild DE, Selby JV, Sinnock P, Browner WS, Braveman P, Showstack JA. Lower-extremity amputation in people with diabetes. Epidemiology and prevention. Diabetes Care 1989; 12: 24-31.
5. 5 Boulton AJ. Lowering the risk of neuropathy, foot ulcers and amputations. Diabet Med 1998; 15: S57-9: S57-S59.
6. 6 Vinik AI, Suwanwalaikorn S, Stansberry KB, Holland MT, McNitt PM, Colen LE. Quantitative measurement of cutaneous perception in diabetic neuropathy. Muscle Nerve 1995; 18: 574-584.
7. 7 Eriksson KF, Nilsson H, Lindgarde F et al. Diabetes mellitus but not impaired glucose tolerance is associated with dysfunction in peripheral nerves. Diabet Med 1994; 11: 279-285.
8. 8 Valk GD, de Sonnaville JJ, van Houtum WH et al. The assessment of diabetic polyneuropathy in daily clinical practice: reproducibility and validity of Semmes Weinstein monofilaments examination and clinical neurological examination. Muscle Nerve 1997; 20: 116-118.
9. 9 Valk GD, Nauta JJ, Strijers RL, Bertelsmann FW. Clinical examination versus neurophysiological examination in the diagnosis of diabetic polyneuropathy. Diabet Med 1992; 9: 716-721.
10. 10 Cromme PVM, Mulder JD, Rutten GEHM, Zuidweg J, Thomas S. A Standard for Diabetes Mellitus Type II. Amsterdam: Dutch College of General Practitioners, 1989.
11. 11 Boulton AJ, Gries FA, Jervell JA. Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy. Diabet Med 1998; 15: 508-514.
12. 12 Wilm S, Gotz C. Patients with a 'diabetic foot': prevention, diagnostics and therapy as seen by general practitioners. Huisarts Wet 1994; 37: 30-32.
13. 13 Valk GD, Grootenhuis PA, Bouter LM, Bertelsmann FW. Complaints of neuropathy related to the clinical and neurophysiological assessment of nerve function in patients with diabetes mellitus. Diabetes Res Clin Pract 1994; 26: 29-34.
14. 14 Bouma M, Dekker JH, van Eijk JTM, Schellevis FG, Kriegsman DMW, Heine RJ. Improving Diabetes Care in General Practice: Metabolic Control, Symptoms and Morbidity of Type 2 Diabetic Patients in a General Practice Network, Dissertation. Amsterdam: EMGO-Institute, Vrije Universiteit, 1999.
15. 15 Grootenhuis PA, Snoek FJ, Heine RJ, Bouter LM. Development of a type 2 diabetes symptom checklist: a measure of symptom severity. Diabet Med 1994; 11: 253-261.
16. 16 Brown MJ, Asbury AK. Diabetic neuropathy. Ann Neurol 1984; 15: 2-12.
17. 17 Anonymous. Statistical Package for the Social Sciences Advanced Statistics Reference Guide. Chicago: SPSS Inc, 1997.
18. 18 Dyck PJ, Karnes JL, Daube J, O'Brien P, Service FJ. Clinical and neuropathological criteria for the diagnosis and staging of diabetic polyneuropathy. Brain 1985; 108: 861-880.
19. 19 Anonymous. Factors in development of diabetic neuropathy. Baseline analysis of neuropathy in feasibility phase of Diabetes Control and Complications Trial (DCCT). The DCCT Research Group. Diabetes 1988; 37: 476-481.
20. 20 Allen C, Shen G, Palta M, Lotz B, Jacobson R, D'Alessio D. Long-term hyperglycemia is related to peripheral nerve changes at a diabetes duration of 4 years. The Wisconsin Diabetes Registry. Diabetes Care 1997; 20: 1154-1158.
21. 21 Franklin GM, Kahn LB, Baxter J, Marshall JA, Hamman RF. Sensory neuropathy in non-insulin-dependent diabetes mellitus. The San Luis Valley Diabetes Study. Am J Epidemiol 1990; 131: 633-643.
22. 22 Harris M, Eastman R, Cowie C. Symptoms of sensory neuropathy in adults with NIDDM in the U.S. population. Diabetes Care 1993; 16: 1446-1452.
23. 23 Walters DP, Gatling W, Mullee MA, Hill RD. The prevalence of diabetic distal sensory neuropathy in an English community. Diabet Med 1992; 9: 349-353.
24. 24 Bouter LM, Dongen Mv. F.pidemiological Research: Design and Interpretation. Bohn: Scheltema & Holkema, 1988.
25. 25 Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 1994; 17: 1281-1289.
26. 26 Maser RE, Laudadio C, DeCherney GS. The effects of age and diabetes mellitus on nerve function. J Am Geriatr Soc 1993; 41: 1202-1204.
27. 27 Thomson FJ, Massen EA, Boulton AJ. The clinical diagnosis of sensory neuropathy in elderly people. Diabet Med 1993; 10: 843-846.